Arctic Bioscience AS (OSL:ABS)
Norway flag Norway · Delayed Price · Currency is NOK
3.570
-0.130 (-3.51%)
Jul 11, 2025, 4:25 PM CET

Arctic Bioscience AS Revenue

In the year 2024, Arctic Bioscience AS had annual revenue of 44.40M NOK with 31.55% growth. Arctic Bioscience AS had revenue of 27.20M in the half year ending December 31, 2024, with 35.54% growth.

Revenue
44.40M
Revenue Growth
+31.55%
P/S Ratio
2.16
Revenue / Employee
2.02M
Employees
22
Market Cap
95.89M

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 44.40M 10.65M 31.55%
Dec 31, 2023 33.76M -713.30K -2.07%
Dec 31, 2022 34.47M 12.95M 60.21%
Dec 31, 2021 21.52M 922.35K 4.48%
Dec 31, 2020 20.59M -9.45M -31.45%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Medistim ASA 603.92M
Nordhealth AS 545.88M
Photocure ASA 532.69M
Omda AS 442.14M
Vistin Pharma ASA 440.66M
Gentian Diagnostics ASA 163.38M
ArcticZymes Technologies ASA 102.97M
Lytix Biopharma AS 608.00K
Revenue Rankings